We are live on !
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$6.14M
(-2.2%)
Cap. Flow
-$20.7M
Cap. Flow % of AUM
Cap. Flow %
-7.52%
Top 10 Holdings %
Top 10 Hldgs %
46.48%
Holding
168
New
21
Increased
21
Reduced
21
Closed
18
Avg Time Held
Equity + Options
2.4
years
Top 10 Avg Time Held
Equity + Options
2
years
Top 20 Avg Time Held
Equity + Options
1.8
years
Avg Time Held Equity only
2.4
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
|
+$9.6M |
| 2 |
Vulcan Infrastructure and Power
VIP
|
+$6.87M |
| 3 |
BRIV
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
|
+$3.38M |
| 4 |
Calumet Specialty Products
CLMT
|
+$2.85M |
| 5 |
HZAC
Horizon Acquisition Corporation
HZAC
|
+$2.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coliseum Acquisition Corp. Unit
MITAU
|
+$14.7M |
| 2 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$6.26M |
| 3 |
FS KKR Capital
FSK
|
+$4.31M |
| 4 |
FAZE
FaZe Holdings Inc. Common Stock
FAZE
|
+$3.4M |
| 5 |
KKR & Co
KKR
|
+$3.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.75% |
| 2 | Healthcare | 24.81% |
| 3 | Miscellaneous | 13.26% |
| 4 | Materials | 12.2% |
| 5 | Communication Services | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
W.P. Carey
WPC
$14.5B
| $438K | 0.16% |
6,126
| – | – |
2017 Q3
16 quarters
|
|
77
Microsoft
MSFT
$3.96T
| $395K | 0.14% |
1,400
| – | – |
2013 Q2
33 quarters
|
|
78
Immunovant
IMVT
$5.7B
| $370K | 0.13% |
42,600
-54,694
| -56% | -$493K |
2021 Q1
2 quarters
|
|
79
Globus Medical
GMED
$10.2B
| $355K | 0.13% |
4,631
| – | – |
2019 Q1
10 quarters
|
|
|
IBER
80
DELISTED
Ibere Pharmaceuticals
IBER
| $349K | 0.13% |
36,000
| – | – |
2021 Q2
1 quarter
|
|
81
Conagra Brands
CAG
$6.7B
| $339K | 0.12% |
10,000
| – | – |
2017 Q3
16 quarters
|
|
82
Meta Platforms (Facebook)
META
$1.8T
| $336K | 0.12% |
990
| – | – |
2021 Q1
2 quarters
|
|
83
PSQ Holdings Warrants
PSQH.WS
| $307K | 0.11% |
+26,666
| New | +$19.3K |
2021 Q3
0 quarters
|
|
84
Apple
AAPL
$5T
| $297K | 0.11% |
2,100
| – | – |
2013 Q2
33 quarters
|
|
|
QTEKW
85
DELISTED
QualTek Services Inc. Warrant
QTEKW
| $288K | 0.1% |
25,000
| – | – |
2021 Q2
1 quarter
|
|
86
Brightstar Lottery PLC
BRSL
$1.72B
| $276K | 0.1% |
10,500
-97,000
| -90% | -$2.06M |
2019 Q1
10 quarters
|
|
|
MSACW
87
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
| $256K | 0.09% |
22,222
| – | – |
2021 Q2
1 quarter
|
|
88
FS Bancorp
FSBW
$349M
| $253K | 0.09% |
7,300
+146
| +2% | +$5.01K |
2018 Q4
11 quarters
|
|
89
Protara Therapeutics
TARA
$138M
| $252K | 0.09% |
36,479
+315
| +0.9% | +$2.46K |
2020 Q1
6 quarters
|
|
|
WARR
90
DELISTED
Warrior Technologies Acquisition Company
WARR
| $245K | 0.09% |
25,000
| – | – |
2021 Q2
1 quarter
|
|
91
Codexis
CDXS
$145M
| $233K | 0.08% |
+10,000
| New | +$237K |
2021 Q3
0 quarters
|
|
92
CRISPR Therapeutics
CRSP
$4.84B
| $224K | 0.08% |
2,000
| – | – |
2021 Q2
1 quarter
|
|
93
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $216K | 0.08% |
29,566
| – | – |
2021 Q1
2 quarters
|
|
|
IBER.WS
94
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
| $207K | 0.08% |
18,000
| – | – |
2021 Q2
1 quarter
|
|
95
Jumia Technologies
JMIA
$770M
| $182K | 0.07% |
9,800
| – | – |
2021 Q1
2 quarters
|
|
|
CTIC
96
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $177K | 0.06% |
60,000
| – | – |
2020 Q4
3 quarters
|
|
|
AGAC
97
DELISTED
African Gold Acquisition Corp
AGAC
| $175K | 0.06% |
18,000
-50,000
| -74% | -$483K |
2021 Q2
1 quarter
|
|
98
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $174K | 0.06% |
19
| – | – |
2021 Q1
2 quarters
|
|
|
SIOX
99
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $174K | 0.06% |
80,000
| – | – |
2020 Q4
3 quarters
|
|
|
XLRN
100
DELISTED
Acceleron Pharma
XLRN
| $172K | 0.06% |
+1,000
| New | +$131K |
2021 Q3
0 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q3 2021 Portfolio in Review
As of Q3 2021, David M. Knott held 168 positions worth $275M, down 2.2% from $281M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
David M. Knott withdrew a net $20.7M in Q3 2021, closing 18 positions and reducing 21 holdings. Its most notable exit was Coliseum Acquisition Corp. Unit, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Miscellaneous.
Against the trend, David M. Knott opened a new position in Coliseum Acquisition Corp. Class A Ordinary Share worth $9.6M.
- David M. Knott's largest Q3 2021 buy was Coliseum Acquisition Corp. Class A Ordinary Share: 984,835 shares worth $9.6M.
- David M. Knott added most to Calumet Specialty Products in Q3 2021, an estimated $2.85M increase.
- David M. Knott's biggest Q3 2021 reduction was FS KKR Capital, cutting an estimated $4.31M.
- David M. Knott fully exited Coliseum Acquisition Corp. Unit in Q3 2021, selling an estimated $14.7M.
- David M. Knott's ten largest holdings make up 46% of its $275M portfolio in Q3 2021.
- David M. Knott opened 21 new positions and closed 18 in Q3 2021.
- David M. Knott's portfolio value fell 2.2% quarter-over-quarter to $275M.
Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.